Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction
Quan Qi, Lei Lu, Haiqing Li, et al.
International Journal of Nanomedicine (2017) Vol. Volume 12, pp. 4835-4848
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Nanomedicines for cardiovascular disease
Bryan Ronain Smith, Elazer R. Edelman
Nature Cardiovascular Research (2023) Vol. 2, Iss. 4, pp. 351-367
Open Access | Times Cited: 72
Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease
Chengming Fan, Jyotsna Joshi, Fan Li, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 80
Recent advancements in nanotechnology based drug delivery for the management of cardiovascular disease
Aziz Ullah, Muneeb Ullah, Sung In Lim
Current Problems in Cardiology (2024) Vol. 49, Iss. 4, pp. 102396-102396
Closed Access | Times Cited: 11
Mitochondria-targeted antioxidant delivery for precise treatment of myocardial ischemia–reperfusion injury through a multistage continuous targeted strategy
Ying Cheng, Daozhou Liu, Chang-xiong Zhang, et al.
Nanomedicine Nanotechnology Biology and Medicine (2019) Vol. 16, pp. 236-249
Closed Access | Times Cited: 64
Biomaterials Loaded with Growth Factors/Cytokines and Stem Cells for Cardiac Tissue Regeneration
Saltanat Smagul, Yevgeniy Kim, Aiganym Smagulova, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5952-5952
Open Access | Times Cited: 53
Simplified α2-macroglobulin as a TNF-α inhibitor for inflammation alleviation in osteoarthritis and myocardial infarction therapy
Weiwei Zheng, Tong Zhou, Yuxiang Zhang, et al.
Biomaterials (2023) Vol. 301, pp. 122247-122247
Closed Access | Times Cited: 17
Nanoparticles as a Novel Platform for Cardiovascular Disease Diagnosis and Therapy
Chuanyun Tang, Kexun Zhou, Di Wu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 8831-8846
Open Access | Times Cited: 8
Hydrogel Scaffolds: Towards Restitution of Ischemic Stroke-Injured Brain
Aswathi Gopalakrishnan, Sahadev Shankarappa, G. K. Rajanikant
Translational Stroke Research (2018) Vol. 10, Iss. 1, pp. 1-18
Closed Access | Times Cited: 54
Nanoparticles: Promising Tools for the Treatment and Prevention of Myocardial Infarction
Qi Pan, Jing Xu, Cen-Jin Wen, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 6719-6747
Open Access | Times Cited: 31
Advances in Nanoparticles in the Prevention and Treatment of Myocardial Infarction
Qidong Wei, Yifei Xiao, Lixin Du, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2415-2415
Open Access | Times Cited: 4
Heart tissue repair and cardioprotection using drug delivery systems
Laura Saludas, Simón Pascual-Gil, Filippo Roli, et al.
Maturitas (2018) Vol. 110, pp. 1-9
Closed Access | Times Cited: 36
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction
Shouwen Zhang, Jingfang Li, Shunpeng Hu, et al.
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 4045-4057
Open Access | Times Cited: 36
Design and applications of protein delivery systems in nanomedicine and tissue engineering
Joëlle Bizeau, Damien Mertz
Advances in Colloid and Interface Science (2020) Vol. 287, pp. 102334-102334
Open Access | Times Cited: 32
Local intramyocardial delivery of bioglass with alginate hydrogels for post-infarct myocardial regeneration
Quan Qi, Yanlun Zhu, Gang Liu, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 129, pp. 110382-110382
Open Access | Times Cited: 27
Cardioprotective Effects of Nanoparticles in Cardiovascular Diseases: A State-of-the-Art Review
Javed Iqbal, Ather Iqbal, Hammad Mukhtar, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 8, pp. 101713-101713
Open Access | Times Cited: 8
Liraglutide Increases VEGF Expression via CNPY2-PERK Pathway Induced by Hypoxia/Reoxygenation Injury
Liu Chong, Yong Liu, Jing He, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 23
Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis
Xiaomin Luo, Cen Yan, Yingmei Feng
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 234-248
Open Access | Times Cited: 20
Liraglutide, a TFEB‐Mediated Autophagy Agonist, Promotes the Viability of Random‐Pattern Skin Flaps
Xuwei Zhu, Xinli Hu, Junsheng Lou, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 18
Current Trends in Biomaterial Utilization for Cardiopulmonary System Regeneration
Adegbenro Omotuyi John Fakoya, David Adeiza Otohinoyi, Joshua Ayodele Yusuf
Stem Cells International (2018) Vol. 2018, pp. 1-32
Open Access | Times Cited: 12
Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/β-catenin
Xiaotong Yang, Xiaoying Ma, Ocholi Don, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Incremental effect of liraglutide on traditional insulin injections in rats with type 2 diabetes mellitus by maintaining glycolipid metabolism and cardiovascular function
Qian Huang, Chan Liu, Jiarui Li, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 8
Evaluation of the potential of nanoparticles containing active substances in selected chronic diseases
Beata Sarecka‐Hujar, Anna Banyś, Aneta Ostróżka-Cieślik, et al.
Advances in Clinical and Experimental Medicine (2020) Vol. 29, Iss. 3, pp. 385-397
Open Access | Times Cited: 8
Cardiovascular effects of antiobesity drugs: are the new medicines all the same?
Mauro Cataldi, Angelo Cignarelli, Francesco Giallauria, et al.
International Journal of Obesity Supplements (2020) Vol. 10, Iss. 1, pp. 14-26
Open Access | Times Cited: 8
Growth Factors: Avenues for the Treatment of Myocardial Infarction and Potential Delivery Strategies
Demin Li, Kang Tian, Jiacheng Guo, et al.
Regenerative Medicine (2022) Vol. 17, Iss. 8, pp. 561-579
Closed Access | Times Cited: 5
Drug delivery for cardiac regeneration
Hoda M. Eltaher, Somiraa S. Said, Labiba K. El‐Khordagui
Elsevier eBooks (2018), pp. 283-321
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top